On the afternoon of August 6, Xinhua Pharmaceutical held a grand appointment ceremony for Professor Zhang Qiang, academician of the Chinese Academy of Engineering, Professor Wang Yiguang, Vice Dean of the School of Pharmacy of Peking University, Professor Yin Lifang of China Pharmaceutical University, He Tongqing, Secretary of the Party Committee and Chairman of Xinhua Pharmaceutical, Xu Wenhui, Deputy Secretary of the Party Committee, Director and General Manager, Zheng Zhonghui, Member of the Party Committee and Deputy General Manager, and Wei Changsheng, Member of the Party Committee and Deputy General Manager, attended the ceremony.
He Tongqing extended a warm welcome and heartfelt thanks to Academician Zhang Qiang, and introduced the company's development history, scientific research and innovation, talent construction, school-enterprise cooperation, etc. He said that Academician Zhang Qiang has been engaged in the research and development of innovative pharmaceutical preparations for a long time, and has profound academic attainments and high professional level. Xinhua Pharmaceutical has always regarded scientific and technological innovation as the core strategy of development, and has continuously increased and invested in the construction of high-end platforms, the introduction of high-end talents, the optimization of innovation mechanisms, and the implementation of innovation incentives. It is believed that under the personal guidance of Academician Zhang Qiang, Xinhua Pharmaceutical's innovative drug research and development, innovation platform construction and talent training will bring more new ideas and help, promote the company's new drug research and development capabilities to a higher level, and inject new vitality into the company's innovation and breakthrough development.
Academician Zhang Qiang expressed his appreciation for Xinhua Pharmaceutical's insistence on inheriting the red gene and always practicing the responsibility of state-owned enterprises, and affirmed the achievements made in scientific research and innovation, talent construction and enterprise development in recent years. He said that as a red pharmaceutical company, Xinhua Pharmaceutical has always anchored a strong enterprise in science and technology and implemented an innovation-driven strategy, which is not only in line with the actual development of the industry, but also highly in line with the strategy of strengthening the country with science and technology. I am very happy to join Xinhua, and I hope to continue to deepen cooperation with enterprises, implement joint research on key technologies of major innovative drugs and preparations, cultivate high-end talents in preparations, accelerate the transformation of scientific research achievements in the field of new drugs, promote the innovation and breakthrough development of pharmaceutical enterprises, and jointly make new and greater contributions to the development of the national pharmaceutical industry and people's health!
Before the appointment ceremony, Academician Zhang Qiang visited the company's exhibition center and new drug R&D center, and made an academic report on the theme of "Nano Transfer Technology and Nano Preparation Industrialization", and exchanged views with the company's scientific researchers on the direction of new drug R&D and innovation.
Academician Zhang Qiang's Profile:
Zhang Qiang, an expert in pharmacy, academician of the Chinese Academy of Engineering, member of the Faculty of the Chinese Academy of Medical Sciences, chief scientist of the National Major Scientific Research Program, national outstanding scientific and technological worker, winner of special government allowance of the State Council, is currently the Boya Chair Professor and Professor of the School of Pharmacy of Peking University, the deputy director of the Academic Committee of the Peking University Health Science Center, the executive deputy director of the Academic Committee of the School of Pharmacy of Peking University, and the director of the Beijing Key Laboratory of Molecular Pharmacy and New Drug Release System.
Zhang Qiang has long been engaged in the research and development of innovative drug formulations and innovative drug delivery systems, including basic and applied translational research on insoluble drugs, antineoplastic drugs and bio-Dafen drug delivery systems. He has made theoretical breakthroughs in the field of nano-cell transport and integrin targeted drug delivery, developed a variety of new delivery systems and marketed them in the field of nano-cell transport and integrin targeted drug delivery, developed a variety of new delivery systems, and produced significant social and economic benefits in Nature communication, AFM, ACS Nano, Nanoletter, ADDR, JCR, More than 300 SCI papers have been published in international high-level journals such as Biomaterials, and SCI citations have entered the top 1% of the ESI ranking in pharmacology and toxicology, and have won important awards such as the second prize of the National Science and Technology Progress Award and the first prize of the Natural Science Award of the Ministry of Education.
Luwang Zibo Channel News Hotline: 0533-3811076
Editor in charge: Liu Zongyao
Source::46 Luwang